Figure 3From: The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s diseaseMean docosahexaenoic acid and plasma vitamin E levels. Effects of 24-week intake of study product on (a) the percentage docosahexaenoic acid (DHA) of total fatty acids in erythrocyte membrane and (b) plasma vitamin E levels (μmol/l) in the intent-to-treat cohort. Error bars represent standard errors. P <0.001 (Mann–Whitney U test).Back to article page